https://busanmbc.co.kr/article/VCJptDEOFCv54spaBikp 

Busan city on the 11th at 4pm Signed an investment memorandum of understanding (MOU) with SmileFND 

for the relocation of the headquarters and the establishment of a new factory.

As a result of the agreement, SmileFND will move its headquarters in Yangsan to Busan’s Gijang-gun industrial complex by 2024.

We plan to invest KRW 18 billion to invest in a new manufacturing plant for raw materials. 

We will hire a total of 150 people including 117 new employees.

It is expected to significantly contribute to the development of regionally related industries 

such as hiring and hiring local talents and the bio-healthcare industry.

SmileFND, established in Yangsan in 2016, has been leading the trend of food culture 

as a company specializing in meat processing and food manufacturing.

In 2021, we will enter the biofood industry by establishing a company-affiliated research center in the Jeong gwan of Gijang-gun.

It is producing plant-(rTG) omega 3, a health functional food.

SmileFND built the latest large-scale bio-manufacturing facility by relocating and integrating the Yangsan 

and Jeonggwan factories, which were separated by investment in Busan.

As a new business, it established a manufacturing plant for omega 3 raw materials and 

set the goal of growing into a pharmaceutical bio company representing Busan.

The meat processing and health functional food market has been transformed into a new business site 

due to the huge increase in purchase demand in the domestic and export markets.

It is expected that there will be an increase in supply and an explosive increase in sales during the relocation. 

The omega 3 raw material drug market is in short supply in domestic production, so if production starts with new investment,

As volume stabilization and import substitution effect can be expected, domestic and overseas market growth and steady demand are expected.

It is estimated that the sales volume will continue to expand in the future.

SmileFND purchases low-purity raw fish oil from overseas and obtains high-purity rTG (EPA and DHA content of 70% or more)

It has the technology and production facilities to manufacture health functional food and high-lipidemia treatment raw materials (EPA, DHA content of 90% or more).

Based on the company-affiliated research institute with excellent researchers with more than 10 years of professional experience, it is an excellent company that is expected to achieve fast results after starting the business.

The city includes the bio-health care industry as one of the seven strategic industries to foster it.

It is a field that is expected to grow rapidly as an alternative to global social problems.

Lee Jun-seung, head of the Digital Economy Innovation Office, said, 

“The bio-healthcare industry is one of the 7 strategic industries in Busan.

As a high value-added new growth engine industry that can improve Busan's industrial structure, SmileFND will

We will provide active support so that it can leap forward as Busan's leading pharmaceutical bio company."